Amphastar Pharma (AMPH) Misses Q1 EPS by 30c
Tweet
Share
E-mail
Get Alerts AMPH Hot Sheet
Join SI Premium – FREE
Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.42, $0.30 worse than the analyst estimate of $0.72. Revenue for the quarter came in at $171.2 million versus the consensus estimate of $176.32 million.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
- Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
